Inovio Pharmaceuticals, Inc. (INO) stock
INONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.69+0.06 (+3.68%)
Close on Nov 18, 2026Market cap $174.74MP/E –Yield –
Inovio Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Inovio Pharmaceuticals's price to book ratio was 27.8× on Nov 11, 2026, against 3.1× a year earlier. Over the last 5 years it ranged from 0.6× to 27.8×, with a median of 1.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 27.8× | +24.8 |
| 2025 | Oct 31, 2025 | 3.0× | +2.4 |
| 2024 | Dec 31, 2024 | 0.6× | −0.3 |
| 2023 | Dec 29, 2023 | 1.0× | −0.5 |
| 2022 | Dec 30, 2022 | 1.5× | −0.9 |
| 2021 | Dec 31, 2021 | 2.3× | −2.3 |
| 2020 | Dec 31, 2020 | 4.6× | −5.1 |
| 2019 | Dec 31, 2019 | 9.7× | +6.1 |
| 2018 | Dec 31, 2018 | 3.6× | +1.3 |
| 2017 | Dec 29, 2017 | 2.3× | −1.2 |
| 2016 | Dec 30, 2016 | 3.5× | +1.0 |
| 2015 | Dec 31, 2015 | 2.5× | −2.2 |
| 2014 | Dec 31, 2014 | 4.8× | −5.0 |
| 2013 | Dec 31, 2013 | 9.7× | +7.6 |
| 2012 | Dec 31, 2012 | 2.2× | +0.7 |
| 2011 | Jul 29, 2011 | 1.4× | – |
See a number that looks wrong?